Skip to content

Clinical trials

Phase 3 Mesothelioma, Malignant trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 3 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20151
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGC Biologics S.p.A.1
Alfacell1
Alliance for Clinical Trials in Oncology1
AstraZeneca1
Ferring Ventures Limited1
INSYS Therapeutics Inc1
Memorial Sloan Kettering Cancer Center1
NRG Oncology1
PrECOG, LLC.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant9
Mesothelioma3
Bile Duct Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Esophageal Neoplasms2
Pancreatic Neoplasms2
Small Cell Lung Carcinoma2
Stomach Neoplasms2
Adrenocortical Carcinoma1
Anus Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.